Mannkind Corp (NASDAQ: MNKD) on Tuesday, plunged -10.30% from the previous trading day, before settling in for the closing price of $4.37. Within the past 52 weeks, MNKD’s price has moved between $4.05 and $7.63.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 35.27% over the last five years. The company achieved an average annual earnings per share of 94.56%. With a float of $294.40 million, this company’s outstanding shares have now reached $303.92 million.
The firm has a total of 407 workers. Let’s measure their productivity. In terms of profitability, gross margin is 74.62%, operating margin of 26.09%, and the pretax margin is 11.17%.
Mannkind Corp (MNKD) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Mannkind Corp is 3.14%, while institutional ownership is 57.97%. The most recent insider transaction that took place on Jun 10 ’25, was worth 256,340. In this transaction Director of this company sold 64,085 shares at a rate of $4.00, taking the stock ownership to the 925,258 shares. Before that another transaction happened on Jun 10 ’25, when Company’s Director proposed sale 64,085 for $4.00, making the entire transaction worth $256,430.
Mannkind Corp (MNKD) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 94.56% per share during the next fiscal year.
Mannkind Corp (NASDAQ: MNKD) Trading Performance Indicators
Mannkind Corp (MNKD) is currently performing well based on its current performance indicators. A quick ratio of 2.11 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.00. Likewise, its price to free cash flow for the trailing twelve months is 55.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.10, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.26 in one year’s time.
Technical Analysis of Mannkind Corp (MNKD)
Analysing the last 5-days average volume posted by the [Mannkind Corp, MNKD], we can find that recorded value of 2.79 million was better than the volume posted last year of 2.04 million. As of the previous 9 days, the stock’s Stochastic %D was 51.29%. Additionally, its Average True Range was 0.18.
During the past 100 days, Mannkind Corp’s (MNKD) raw stochastic average was set at 1.28%, which indicates a significant decrease from 5.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.77% in the past 14 days, which was higher than the 37.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.57, while its 200-day Moving Average is $5.77.
